20.02.2015 Views

Medical -Aid Manager WatchTM Survey for the ... - Alexander Forbes

Medical -Aid Manager WatchTM Survey for the ... - Alexander Forbes

Medical -Aid Manager WatchTM Survey for the ... - Alexander Forbes

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

MAY 2012/05/31 2012/03/01 2012/01/01 2011/06/01 2009/06/01 2007/06/01<br />

MARCH 2012/03/31 2012/01/01 2005/12/01 2011/04/01 2009/04/01 2007/04/01<br />

Month Ending<br />

Previous Month<br />

May 2012<br />

March 2012<br />

<strong>Medical</strong>-<strong>Aid</strong> <strong>Manager</strong> Watch <strong>Survey</strong><br />

December 2007<br />

<strong>Medical</strong> -<strong>Aid</strong> <strong>Manager</strong> Watch TM <strong>Survey</strong><br />

<strong>for</strong> <strong>the</strong> month ending May 2012


MEDICAL-AID MANAGER WATCH SURVEY<br />

Objective - The portfolios in this <strong>Survey</strong> are targeted at <strong>Medical</strong> <strong>Aid</strong>s and are bound by <strong>the</strong> restrictions imposed by Regulation 30 of <strong>the</strong> <strong>Medical</strong> Schemes Act.<br />

Benchmark Methodology CPI - Due to <strong>the</strong> reweighting and rebasing of <strong>the</strong> CPI from January 2009 <strong>the</strong> benchmark numbers reflect a compound of month to month CPI returns. The historical month to month numbers used in calculations are <strong>the</strong> official month to month numbers based on <strong>the</strong> old basket prior to January 2009 and new basket post January<br />

2009. The adjusted CPI(I-Net code: AECPI) figures are shown toge<strong>the</strong>r with statistics below should <strong>the</strong>se numbers be preferred <strong>for</strong> comparison purposes.<br />

Benchmark Methodology CPIX - The benchmark numbers prior to January 2009 reflected a compound of month to month CPIX returns. Due to <strong>the</strong> reweighting and rebasing of <strong>the</strong> CPI and discarding of <strong>the</strong> CPIX numbers from January 2009 <strong>the</strong> historical month to month numbers used in calculations are <strong>the</strong> official month to month numbers based<br />

on <strong>the</strong> old CPIX prior to January 2009 and <strong>the</strong> new CPI basket post January 2009. The CPI excluding owners equivalent rent (I-Net code: AECPIX) and adjusted CPI(I-Net code: AECPI) figures are shown toge<strong>the</strong>r with statistics below should <strong>the</strong>se numbers be preferred <strong>for</strong> comparison purposes.<br />

INVESTMENT DATA TO THE END OF MAY 2012<br />

Fund In<strong>for</strong>mation<br />

Month<br />

Quarter<br />

Year to Date<br />

PERFORMANCE DATA<br />

1 Year<br />

3 Years (p.a.)<br />

Benchmark Classification Portfolio Benchmark Portfolio Benchmark Portfolio Benchmark Portfolio Benchmark Portfolio Benchmark Volatility<br />

ABSOLUTE RETURN FUNDS<br />

Size (R m)<br />

Rank<br />

Cadiz Capital Preservation Fund Headline CPI +3% Pooled<br />

0.30% 0.65% 1.29% 2.81% 2.55% 4.08% 6.82% 9.12% 8.45% 8.05% 2.10% 1333.9 2<br />

Cadiz <strong>Medical</strong> <strong>Aid</strong> Fund Headline CPI +4% Segregated -1.36% 0.74% 0.10% 3.06% 4.13% 4.49% 7.70% 10.12% * * * 226.7 8<br />

Coronation <strong>Medical</strong> Absolute Headline CPI +3% Pooled<br />

-1.04% 0.65% 1.16% 2.81% 4.95% 4.08% 8.37% 9.12% 13.83% 8.05% 4.56% 758.0 4<br />

IS <strong>Medical</strong> Schemes Real Return Focus Headline CPI +4% Pooled Multi-Managed -1.00% 0.74% 0.03% 3.06% 2.56% 4.49% 4.48% 10.12% 10.21% 9.05% 3.50% 182.7 10<br />

Momentum AM <strong>Medical</strong> Provider Fund CPI + 3% (CPIX +3% prior Jan 09) Pooled<br />

-0.90% 0.65% 0.40% 2.81% 3.55% 4.08% 6.97% 9.12% 11.34% 8.05% 5.26% 94.5 11<br />

OMIGSA Capital Builder Headline CPI +4% Pooled<br />

-0.24% 0.74% 0.10% 3.06% 2.47% 4.49% 4.63% 10.12% 6.14% 9.05% 3.46% 1374.5 1<br />

Prescient Positive Return <strong>Medical</strong> <strong>Aid</strong> Fund CPI + 3% (CPIX +3% prior Jan 09) Segregated<br />

-0.69% 0.65% -0.79% 2.81% 1.48% 4.08% 2.50% 9.12% 7.03% 8.05% 2.69% 1106.5 3<br />

Prudential <strong>Medical</strong> <strong>Aid</strong> Fund Headline CPI +5% Segregated -0.92% 0.82% 1.74% 3.30% 6.26% 4.89% 11.88% 11.12% 14.86% 10.05% 5.93% 632.9 6<br />

SIM <strong>Medical</strong> <strong>Aid</strong> Domestic Absolute Headline CPI +5% Segregated<br />

-0.75% 0.82% 0.98% 3.30% 4.61% 4.89% 9.51% 11.12% * * * 397.1 7<br />

STANLIB <strong>Medical</strong> Investment Fund* Headline CPI +4% Pooled (Unit Trust)<br />

0.62% 0.74% 2.95% 3.06% 5.95% 4.49% 9.73% 10.12% 8.82% 9.05% 4.25% 185.6 9<br />

Pooled 635.9<br />

Taquanta <strong>Medical</strong> Absolute Headline CPI +4.5% 0.30% 0.78% 0.88% 3.18% 2.21% 4.69% 5.62% 10.62% 9.08% 9.55% 1.14% 5<br />

MONEY MARKET FUNDS<br />

ABSA Asset Management <strong>Medical</strong>* 50% ALBI : 50% STEFI Segregated<br />

0.15% 0.23% 1.54% 1.66% 3.26% 3.26% 7.78% 8.37% 7.80% 8.49% 1.65% 196.4 5<br />

Cadiz African Harvest Core Money Market STEFI Segregated 0.51% 0.47% 1.51% 1.40% 2.49% 2.33% 5.96% 5.72% 6.93% 6.56% 0.31% 391.5 4<br />

Gryphon Domestic Specialist MM STEFI Segregated<br />

0.50% 0.47% 1.49% 1.40% 2.47% 2.33% 6.02% 5.72% 7.08% 6.56% 0.30% 963.1 2<br />

Investec Stable Money Fund STEFI Pooled<br />

0.55% 0.47% 1.64% 1.40% 2.73% 2.33% 6.67% 5.72% 7.50% 6.56% 0.27% 803.4 3<br />

Taquanta <strong>Medical</strong> Cash STEFI Segregated 0.59% 0.47% 1.76% 1.40% 2.93% 2.33% 7.14% 5.72% 7.68% 6.56% 0.19% 6111.4 1<br />

BALANCED FUNDS<br />

Allan Gray Life Stable <strong>Medical</strong> Portfolio Headline CPI +3% Pooled<br />

0.61% 0.65% 1.43% 2.81% 2.67% 4.08% 8.60% 9.12% 9.97% 8.05% 2.17% 1463.1 1<br />

Foord <strong>Medical</strong> 50% domestic bonds: 50% domestic equities Segregated<br />

-1.33% -1.13% 1.43% 0.47% 6.49% 4.26% 10.92% 7.57% 13.26% 12.84% 4.60% 222.3 3<br />

OMIGSA MacroSolutions <strong>Medical</strong> <strong>Aid</strong> Portfolio Headline CPI +5% Segregated<br />

-0.27% 0.82% 1.70% 3.30% 5.17% 4.89% 10.55% 11.12% 12.78% 10.05% 4.88% 399.4 2<br />

STATISTICS<br />

Combination of old CPIX and new CPI# 0.41% 2.07% 2.84% 6.12% 5.05% 1.09%<br />

Consumer Price Inflation (Old/New combined CPI)# 0.41% 2.07% 2.84% 6.12% 5.05% 1.09%<br />

Consumer Price Inflation excluding OER [I-Net code: AECPIXU] 0.49% 2.15% 2.91% 6.36% 5.15% 1.23%<br />

Consumer Price Inflation (Headline CPI) [I-Net code: AECPI] 0.41% 2.07% 2.84% 6.12% 5.05% 1.09%<br />

<strong>Medical</strong> Consumer Price Inflation 0.23% 4.48% 4.57% 5.23% 5.94% 4.27%<br />

FTSE / JSE All Share Index (Free Float) -3.59% -2.26% 5.10% 5.08% 16.43% 14.51%<br />

FTSE / JSE SWIX All Share Index -3.11% -0.45% 6.98% 9.14% 18.18% 13.06%<br />

Short Term Fixed Interest Rate Index 0.47% 1.40% 2.33% 5.72% 6.56% 0.26%<br />

All Bond Index -0.01% 1.92% 4.20% 11.06% 10.62% 4.93%<br />

Number Of Participants 19 19 19 19 17 17<br />

17478.8<br />

Index<br />

Inflation figures lagged by one month<br />

* Global Funds<br />

Reasonable use of <strong>the</strong> survey may be made <strong>for</strong> purposes of comment and study provided that full acknowledgement is made to "<strong>Alexander</strong> <strong>Forbes</strong> Asset Consultants".<br />

** Please see final page <strong>for</strong> Disclaimers and Glossary **<br />

# Please refer to Benchmark Methodology at <strong>the</strong> top of <strong>the</strong> page


3 year returns<br />

MEDICAL-AID MANAGER WATCH SURVEY<br />

Risk-Return Scatterplot of <strong>Medical</strong> <strong>Aid</strong> <strong>Manager</strong>s <strong>for</strong> 3 years to 31 May 2012<br />

Prudential <strong>Medical</strong> <strong>Aid</strong> Fund<br />

14.05%<br />

13.05%<br />

12.05%<br />

Coronation <strong>Medical</strong><br />

Absolute<br />

OMIGSA MacroSolutions <strong>Medical</strong><br />

<strong>Aid</strong> Portfolio<br />

Foord <strong>Medical</strong><br />

11.05%<br />

10.05%<br />

Allan Gray Life<br />

Stable <strong>Medical</strong> Portfolio<br />

IS <strong>Medical</strong> Schemes<br />

Real Return Focus<br />

Momentum AM <strong>Medical</strong><br />

Provider Fund<br />

9.05%<br />

Taquanta <strong>Medical</strong> Absolute<br />

Cadiz Capital Preservation Fund<br />

STANLIB <strong>Medical</strong> Investment Fund*<br />

8.05%<br />

Taquanta <strong>Medical</strong> Cash<br />

7.05%<br />

ABSA Asset Management <strong>Medical</strong>*<br />

Investec Stable Money Fund<br />

Gryphon Domestic<br />

Prescient Positive Return<br />

Specialist MM<br />

<strong>Medical</strong> <strong>Aid</strong> Fund<br />

Cadiz African Harvest Core Money<br />

STeFI<br />

Market<br />

6.05%<br />

OMIGSA Capital Builder<br />

0.10% 2.10% 4.10%<br />

3 year volatility<br />

Reasonable use of <strong>the</strong> survey may be made <strong>for</strong> purposes of comment and study provided that full acknowledgement is made to "<strong>Alexander</strong> <strong>Forbes</strong> Asset Consultants".


MEDICAL-AID MANAGER WATCH SURVEY<br />

EXPLANATORY NOTES<br />

Index<br />

General Disclaimers :<br />

This document has been prepared <strong>for</strong> use by clients of <strong>the</strong> <strong>Alexander</strong> <strong>Forbes</strong> Group. Any o<strong>the</strong>r third party that is not a client of <strong>the</strong> <strong>Alexander</strong> <strong>Forbes</strong> Group and <strong>for</strong><br />

whose specific use this document has not been supplied, must be aware that <strong>Alexander</strong> <strong>Forbes</strong> Group shall not be liable <strong>for</strong> any damage, loss or liability of any nature<br />

incurred by any third party and resulting from <strong>the</strong> in<strong>for</strong>mation contained herein.<br />

The in<strong>for</strong>mation contained herein is supplied on an "as is" basis and has not been compiled to meet any third party’s individual requirements. It is <strong>the</strong> responsibility of<br />

any third party to satisfy himself or herself, prior to relying on this in<strong>for</strong>mation that <strong>the</strong> contents meets <strong>the</strong> third party’s individual requirements.<br />

Nothing in this document, when read in isolation and without professional advice, should be construed as solicitation, offer, advice, recommendation, or any o<strong>the</strong>r<br />

enticement to acquire or dispose of any financial product, advice or investment, or to engage in any financial transaction or investment. A third party should consult<br />

with an authorised financial advisor prior to making any financial decisions.<br />

<strong>Alexander</strong> <strong>Forbes</strong> has taken all reasonable steps to ensure <strong>the</strong> quality and accuracy of <strong>the</strong> contents of this document and encourages all readers to report incorrect and<br />

untrue in<strong>for</strong>mation, subject to <strong>the</strong> right of <strong>Alexander</strong> <strong>Forbes</strong> to determine, in its sole and absolute discretion, <strong>the</strong> contents of this document. Irrespective of <strong>the</strong><br />

attempts by <strong>Alexander</strong> <strong>Forbes</strong> to ensure <strong>the</strong> correctness of this document, <strong>Alexander</strong> <strong>Forbes</strong> does not make any warranties or representations that <strong>the</strong> content will in all<br />

cases be true, correct or free from any errors.In particular, certain aspects of this document might rely on or be based on in<strong>for</strong>mation supplied to <strong>Alexander</strong> <strong>Forbes</strong> by<br />

o<strong>the</strong>r persons or institutions.<br />

<strong>Alexander</strong> <strong>Forbes</strong> has attempted to ensure <strong>the</strong> accuracy of such in<strong>for</strong>mation, but shall not be liable <strong>for</strong> any damage, loss or liability of any nature incurred by any party<br />

and resulting from <strong>the</strong> errors caused by incorrect in<strong>for</strong>mation supplied to <strong>Alexander</strong> <strong>Forbes</strong>.<br />

Per<strong>for</strong>mance figures are shown gross of fees and taxes. Past history is not necessarily a guide to future per<strong>for</strong>mance.<br />

Quantitative figures are calculated on 3 year per<strong>for</strong>mance returns.<br />

Per<strong>for</strong>mance should not be judged over a short period of time.<br />

FAIS Notice and Disclaimer: This in<strong>for</strong>mation is not advice as defined and contemplated in <strong>the</strong> Financial Advisory and Intermediary Services Act, 37 of 2002, as amended.<br />

<strong>Alexander</strong> <strong>Forbes</strong> shall not be liable <strong>for</strong> any actions taken by any person based on <strong>the</strong> correctness of this in<strong>for</strong>mation.<br />

General :<br />

GIPS is a trademark owned by <strong>the</strong> CFA Institute.<br />

Statistical Definitions :<br />

The Median is <strong>the</strong> value above or below which half <strong>the</strong> managers fall.<br />

The Upper Quartile is <strong>the</strong> value above which one quarter of <strong>the</strong> managers fall.<br />

The Lower Quartile is <strong>the</strong> value below which one quarter of <strong>the</strong> managers fall.<br />

Risk Anlysis Definitions :<br />

"Volatility" is <strong>the</strong> annualised standard deviation of <strong>the</strong> manager's monthly returns.<br />

"Volatility" is a measure of <strong>the</strong> variability of <strong>the</strong> manager's returns.<br />

"Return to Risk" is <strong>the</strong> return divided by <strong>the</strong> "Volatility"<br />

"Return to Risk" is a measure of <strong>the</strong> return earned per unit of risk taken.<br />

"Active return" is <strong>the</strong> return earned by <strong>the</strong> manager less <strong>the</strong> return on <strong>the</strong> benchmark.<br />

"Active Return" is a measure of <strong>the</strong> value that <strong>the</strong> manager has added or detracted over <strong>the</strong> benchmark return.<br />

"Tracking Error" is <strong>the</strong> annualised standard deviation of <strong>the</strong> monthly "Active Returns".<br />

"Tracking Error" is a measure of <strong>the</strong> variability of <strong>the</strong> manager's returns relative to <strong>the</strong> benchmark returns.<br />

"In<strong>for</strong>mation Ratio" is <strong>the</strong> "Active Return" divided by <strong>the</strong> "Tracking Error".<br />

"In<strong>for</strong>mation Ratio" is a measure of <strong>the</strong> value added per unit of risk taken relative to <strong>the</strong> benchmark.<br />

"Sortino Ratio (Capital Loss)" measures whe<strong>the</strong>r <strong>the</strong> return in excess of a zero benchmark was sufficient to cover <strong>the</strong> downside volatility/risk inherent in <strong>the</strong> investment<br />

ie whe<strong>the</strong>r capital was indeed preserved.<br />

"Sortino Ratio (Inflation)" measures whe<strong>the</strong>r <strong>the</strong> return in excess of a inflationary benchmark was sufficient to cover <strong>the</strong> downside volatility/risk inherent in <strong>the</strong><br />

investment ie whe<strong>the</strong>r capital was protected in real terms.<br />

GIPS - Global Investment Per<strong>for</strong>mance Standards<br />

Ethical principles to achieve full disclosure and fair presentation of investment per<strong>for</strong>mance

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!